Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Population pharmacokinetics of ethambutol in African children: a pooled analysis

Journal of Antimicrobial Chemotherapy(2022)10.1093/jac/dkac127Source: DataRank Database

Population pharmacokinetics of ethambutol in African children: a pooled analysis is a research paper published in Journal of Antimicrobial Chemotherapy (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (26 grants)Impact (FWCI 0.98)OA: hybridTopics (62)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Helen McIlleron ORCID,Mahmoud Tareq Abdelwahab ORCID,Adrie Bekker ORCID,Anneke C. Hesseling ORCID,Chishala Chabala ORCID

Live enrichment

PubMed:35466379 PMC:PMC9633720 OpenAlex:https://openalex.org/W4224706206

NIAID

Grant: AI068634

NIAID

Grant: AI068636

NIAID

Grant: AI106701

National Institute of Allergy and Infectious Diseases

Grant: AI068632

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Grant: R01HD069175

Wellcome Trust

Grant: 206379/Z/17/Z

NIAID NIH HHS

Grant: UM1 AI068632

NIAID NIH HHS

Grant: UM1 AI068636

NIAID NIH HHS

Grant: UM1 AI068634

Medical Research Council

Grant: MR/L004445/1

MICA: randomized trial of therapy shortening for minimal TB with new WHO-recommended doses and FDC drugs in African/Indian HIV+/HIV- children

NIAID NIH HHS

Grant: U01 AI068632

NIAID NIH HHS

Grant: UM1 AI106701

Medical Research Council

Grant: MC_UU_12023/26

Paediatric and adolescent infections

National Institutes of Health

Grant: 3UM1AI106701-12S1

AIDS Clinical Trial Group Laboratory Center

Wellcome Trust

Grant: 206379

Pharmacometrics to advance novel regimens for drug-resistant tuberculosis (PandrTB)

National Institutes of Health

Grant: 5R01HD069175-05

Optimal dosing of 1st line antituberculosis and antiretroviral drugs in children

National Institutes of Health

Grant: 3U01AI068632-04S3

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group

National Institutes of Health

Grant: 5UM1AI068634-09

Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)

National Institutes of Health

Grant: 3UM1AI068636-19SC

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

National Institutes of Health

Grant: 5U01AI068634-03

Statistical and Data Management Center for the AIDS Clinical Trials Group

National Institute of Mental Health

Infant Maternal Pediatric Adolescent AIDS Clinical Trials Group

Medical Research Council

Wellcome Trust

Adult Clinical Trial Group

Wellcome Trust

FWCI

0.98

Citation Percentile

0.7%

Citation Trend

2022

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1093/jac/dkac127

publisherhttps://doi.org/10.1093/jac/dkac127

publisherhttps://academic.oup.com/jac/article-pdf/77/7/1949/48306573/dkac127.pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35466379

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9633720

Fields of Study

Drug-Induced Ocular ToxicityHIV/AIDS drug development and treatmentPharmacovigilance and Adverse Drug Reactions03 medical and health sciences0302 clinical medicineAnti-HIV AgentsAntitubercular AgentsChildChild, PreschoolEthambutolHIV InfectionsHumansInfant, NewbornLopinavirRitonavir

MeSH Terms

Antitubercular AgentsChildChild, PreschoolEthambutolHumansInfant, NewbornHIV InfectionsAnti-HIV AgentsRitonavirLopinavir

Keywords

EthambutolPharmacokineticsMedicineRitonavirCmaxBioavailabilityLopinavirPopulationDosingPharmacologyPediatricsIsoniazidViral loadTuberculosisHuman immunodeficiency virus (HIV)ImmunologyAntiretroviral therapyEnvironmental healthAnti-HIV AgentsAntitubercular AgentsHIV InfectionsFOS: Health sciencesEfficacy and Safety of Antiretroviral Therapy for HIVRheumatologyHealth SciencesPathologyHumansChildOriginal ResearchFOS: Clinical medicineOcular Toxicity and Retinal Disorders from MedicationsInfant, NewbornOcular ToxicityOphthalmologyInfectious DiseasesSystemic Lupus Erythematosus and Antiphospholipid SyndromeChild, Preschool

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being